Chemomab Therapeutics Ltd. Assets, Noncurrent
Chemomab Therapeutics Ltd. (CMMB) had Assets, Noncurrent of $387.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AssetsNoncurrent · last filed 2026-03-23
- 2025-12-31: Assets, Noncurrent $387.00K.
- 2025-06-30: Assets, Noncurrent $515.00K.
- 2024-12-31: Assets, Noncurrent $924.00K.
- 2024-06-30: Assets, Noncurrent $1.09M.
| Period end | Assets, Noncurrent |
|---|---|
| 2025-12-31 | $387.00K 20-F · filed 2026-03-23 |
| 2025-06-30 | $515.00K 6-K · filed 2025-08-14 |
| 2024-12-31 | $924.00K 20-F · filed 2026-03-23 |
| 2024-06-30 | $1.09M 6-K · filed 2024-08-21 |
| 2023-12-31 | $1.25M 20-F · filed 2025-04-04 |
| 2023-06-30 | $1.14M 6-K · filed 2023-08-14 |
| 2023-03-31 | $1.24M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.33M 20-F · filed 2024-03-28 |
| 2022-09-30 | $1.49M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.55M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $1.62M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.67M 10-K · filed 2023-03-20 |
| 2021-09-30 | $1.60M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.68M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $600.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $637.00K 10-K · filed 2022-03-30 |
| 2019-12-31 | $1.54M 10-K · filed 2020-03-17 |
| 2018-12-31 | $1.84M 10-K · filed 2020-03-17 |